# Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA

Source: https://onco.cc/trials/nct06440902/  
OnCo record `nct06440902` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of cetuximab in colorectal cancer, run by Fudan University, now recruiting.

## Summary

Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA is a phase 2, interventional study registered as NCT06440902 by Fudan University, with a registry enrolment figure of 1100 participants, started 2023-12-28 and due to reach its primary completion in 2028-09-01. Interventions recorded: Cetuximab. Conditions listed: Colorectal Cancer Metastatic. Primary outcome: Detection rate of NeoRAS WT. Colorectal eligibility wording from the registry: "Metastatic colorectal cancer with tissue RAS mutation-type;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06440902
- Phase: 2
- Setting: Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA: an Open, Prospective, Phase II Study
- Sponsor: Fudan University
- Enrolled: 1100

## Sources

- ClinicalTrials.gov NCT06440902: https://clinicaltrials.gov/study/NCT06440902

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/), [MRD / molecular residual disease testing](https://onco.cc/technologies/mrd-testing/)
- drugs: [Cetuximab](https://onco.cc/drugs/cetuximab/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06440902.json